Skip to main content
Indian Journal of Ophthalmology logoLink to Indian Journal of Ophthalmology
. 2024 Sep 27;72(10):1412–1423. doi: 10.4103/IJO.IJO_2899_22

Nutrition and diet for dry eye disease: Insights toward holistic management

Nikhil S Bhandarkar 1,, Keerthy Shetty 2, P Narendra 2, Anupama Kiran 2, Rohit Shetty 2, K Bhujang Shetty 2
PMCID: PMC11573025  PMID: 39331431

Abstract

Dry eye disease (DED) is one of the most common eye problems in the aging population. Hyperosmolarity triggers the immune response in DED and consequently activates the self-perpetuating immune cycle, leading to chronic damage of the ocular surface. This event causes symptoms such as a burning sensation, irritation, redness, photophobia, and blurred vision in DED patients. Subsequently, the quality of life gets significantly affected. The rising demand for DED management and treatment solutions, and the desirable outcomes from innovative therapies that draw global interest provide evidence to demonstrate the role of diet and nutrition in DED. Nutritional deficiency and a Westernized diet contribute to the chronic systemic progression of DED symptoms. It has been revealed in several published studies that the use of nutrients and dietary supplements improves the ocular surface and acts as a protective factor against DED. - We reviewed nutrition and dietary aspects in managing DED and its associated consequences, based on published studies, and reached an evidence-based conclusion.

Keywords: Diet, dry eye disease, metabolic syndrome


Dry eye disease (DED) is the consequence of tear film alteration, which is either caused by aqueous deficiencies (aqueous-deficient dry eye [ADDE]) or elevated evaporation rate (evaporative dry eye [EDE]), ultimately due to lipids’ modulations. ADDE and EDE lead to an increase in the solute concentration of tear film, consequently forming tear hyperosmolarity.[1] These conditions result in chronic inflammation that plays a crucial role in dry eye (DE) pathogenesis. Aging and oxidative stress trigger DED, where reactive oxygen species (ROS) form that may cause DE pathology that leads to chronic inflammation and cell damage.[2] Interestingly, the ocular surface of DED patients shows a distinct immune cell population. Sethu et al.[3] reported that DED severity was linked to higher levels of activated neutrophils and gamma delta T cells, as well as lower levels of natural killer cells.

DED can cause a broad range of signs and symptoms that stretch from foreign object sensation to severe visual impairment. In addition, the sensation of itching, grit, and DE have been reported to be the most frequent symptoms. Several medical treatments have been suggested to manage DED. In moderate cases, lubricants and tear supplements are utilized. Similarly, the use of steroids, autologous serum enriched or deficient in platelet factors, and immunomodulators such as cyclosporin A.[4] Hygienic practice and environmental modifications have also been demonstrated to decrease the damage of tear film, for instance, glasses with lateral protection and humidifier usage have been shown to slow down DED progression.

Several studies have shown the contribution of diets and nutrients in the management and prevention of DED.[5,6,7] The most common nutritional deficiency associated with DED is vitamin A.[8,9] Likewise, lower vitamin D was found in the tear of DED patients, which signifies its association with DED severity.[10] Murugeswari et al.[11] revealed that vitamin D has a therapeutic potential as it protects the retinal pigment epithelium and stimulates angiogenesis under hyperoxia conditions. Similarly, dietary supplements consisting of polyunsaturated fatty acids (PUFAs), for example, omega-3 or omega-6 fatty acids (FAs), have been reported to improve the tear film and exert preventive effects against DED.[12,13] Furthermore, the Mediterranean diet, which is a rich source of PUFA, has shown ample evidence of beneficial improvement against cardiovascular diseases as well as DED.[14,15] Dietary PUFA has preventive factors against DE symptoms, and it could promote an anti-inflammatory/proinflammatory ratio and reduce proinflammatory prostaglandin levels in the lacrimal gland.[16,17] The focus of this review is to explore various studies of diets/nutrients and take an in-depth look at them to present the potential evidence for the treatment of DED and their mechanism of prevention.

Effects of diet on the molecular pathway

The ocular surface is constantly exposed to biotic and abiotic stimuli, particularly sunlight with UV wavelengths, which induces oxidative stress through accelerating the creation of ROS. Oxidative stress has a crucial role in the progression of Sjögren syndrome, a systemic autoimmune disease, which affects the lacrimal and leads to severe DED. Elevated oxidative stress causes an increase in ROS, lipid peroxidation-associated membrane damage, and inflammatory reactions in DEs.[18] Moreover, aging is a well-known factor for oxidative stress. With aging, the concentration of ROS increases; in contrast, the concentration of endogenous antioxidant species significantly reduces with aging.[19] Hyperosmolarity is a major factor in DED and causes an acute immune reaction.[20] Oxidative stress–induced activation of an adaptive immune reaction triggers the inflammatory cascade, consequently causing damage to the ocular surface.[20] Several key molecular and cellular mediators linked to DED are involved in the inflammatory cascade resulting in DED. For instance, cytokines are signaling molecules that are responsible for intercellular communication. The osmotic stress and inflammatory or mechanical insults cause upregulation of the production of proinflammatory cytokines in the tears of DE patients.[21] A clinical study reported that the tear of DED patients showed the upregulation of cytokines such as interleukin (IL)‐1, IL‐6, tumor necrosis factor (TNF)-α, and transforming growth factor-β1.[21] Jackson et al.[22] revealed that interferon-gamma (IFN-γ) altered significantly in ocular surface diseases and showed a correlation with tear hyperosmolarity and ocular surface staining. This study supports evidence that a specific cytokine as a biomarker could be a potential tool for the diagnosis of DED diseases in future for clinical practice. Likewise, IL-8 is regularly observed in the tear film and conjunctiva of patients with DEs.[21] Acera et al.[23] reported that the tears of patients with ocular surface disease showed an increased pro‐MMP‐9 level and higher activity of MMP-9.

Methods

Search strategies

An electronic literature search was conducted in PubMed, Web of Science, and Google Scholar to sort human studies, rodent studies, and molecular studies published till 2022 and written in English, including the following keywords or word phrases: dry eye diseases (DED), DED + diet, DED + dietary intervention, DED + functional foods, and DED + vitamins. The articles within the search results were further manually curated for relevance to dietary influences in DED.

Study criteria

To be eligible, a report had to fulfill the following criteria: first, it had to be an original study regarding the relationship between dietary intervention and patients with DED. To reduce inaccuracy, only the most common dietary consumption was characterized from the articles. Smokers, diabetics, subjects who had recent surgeries or medication that affects the dietary outcomes, and women who were pregnant or might become pregnant were excluded from this review.

Dietary nutrition and DED management

In recent years, there has been increasing attention to the lifestyle factors associated with DED as the cost of public health and financial burden increases with the aging population. Lifestyle intervention [see Tables 1 and 2], precisely diet, could be a promising strategy to be more cost-efficient than disease treatment at the population level for DED management [see Fig. 1].

Table 1:

In vivo and in vitro studies of DED and dietary intervention

Treatment Study and year Study design Disease Intervention Main findings
Calorie restriction Kawashima et al.[24] In vivo study Age-related DED 6 months- calorie restriction, modified diet Reduced body weight, preserved the lacrimal functions
Vitamins Zhang et al.[25] In vivo study DEDs Eye drops containing vitamin E for 5 and 10 days Soothed the tear film lipid layer, enhanced TBUT and corneal epithelial damages, reduced ROS production and inflammatory molecules
Vicario-de-la-Torre et al.[65] In vivo and in vitro DEDs Liposome-based artificial tear containing vitamin E Reduced signs and symptoms of DED, enhanced the lipid layer of the tear film
Zhang et al.[25] In vivo study DEDs Vitamin A-containing eye drop Suppressed the apoptosis of epithelial cells in mice with DED
PUFA James et al.[26] In vivo study DEDs 0.5% Docosahexaenoic acid in diet for 77 days Crossed the blood–retina barrier, protected against lipid peroxidation
Amino acids Pehlivan et al.[27] In vivo and in vitro study DEDs Cyclosporin A Improved the healing time
Mori et al.[28] In vivo study DEDs PES_103- synthetic - Matrix metalloproteinases (MMPs) inhibitor-artificial tears- twice a day Enhanced tear production
Functional food Chung et al. 2012[29] In vivo study Ovalbumin allergen-induced allergic conjunctivitis 18 days protocol
Ovalbumin- 0, 7, 15, and 18 days
Curcumin- 14 and 17 days
Curcumin decreased infiltration of IL-4–and IL-5–producing cells in the conjunctival stroma
Chen et al. 2010[30] In vitro study NaCl 90 mM induced hyperosmoticity Cells exposed to the hyperosmotic medium for 24 h followed by curcumin for 30 min Curcumin decreased the elevated IL-1β, IL-6, and TNF-α proteins induced by hyperosmotic stress
Hong et al. 2020[7] In vivo and in vitro study PBS-diluted scopolamine injection- twice daily 2.5 mg/ml A. koraiensis extraction- oral administration Improved TBUT and enhanced tear production from the lacrimal glands

DED=dry eye disease, IL=interleukin, PBS=phosphate-buffered saline, ROS=reactive oxygen species, TBUT=tear film breakup time, TNF-α=tumor necrosis factor-alpha, A. koraiensis=Aster koraiensis

Table 2.

Dietary intervention and human studies

graphic file with name IJO-72-1412-g002.jpg

Figure 1.

Figure 1

Self-perpetuating cycle of dry eye diseases and it’s management through dietary components

Dietary restriction

Excessive consumption of calories causes acceleration in aging and oxidative stress and increases the risk of aging-associated diseases including obesity, diabetes, and cardiovascular disease. Caloric restriction (CR) diets have been shown to improve health and extend lifespan by modulating physiological and pathophysiological changes associated with aging and oxidative stress, despite their complexity.[46,47,48] CR has demonstrated attenuation of oxidative stress-associated impairment in the lacrimal gland with the protection of lacrimal gland functions in rats.[24] One clinical study showed that a CR diet for 2 months improved DED as well as the quality of life and productivity.[31] Moreover, a Mediterranean diet supplemented with extra virgin olive oil and nuts showed a significant improvement in DE signs compared to standard intervention.[32]

Vitamins

Vitamin A is a crucial factor for visual pigments and the integrity of the ocular surface.[49] Alanazi et al.[33] showed that short-term oral vitamin A supplementation is crucial for preserving the health of the ocular tear film and can reduce the symptoms of DED. Another study has shown that oral vitamin A supplements delivered results more efficiently compared to topically applied vitamin A eye drops for the management of eye dryness.[34] Vitamin D has the potential to enhance the tear quality and ocular surface conditions in DED.[35,36] The fundamental mechanism of vitamin D could be its antioxidation, anti-inflammatory, and immune regulatory effects.[50] Macri et al.[37] evaluated the impacts of preservative-free eyedrops comprising hyaluronic acid 0.15% and vitamin B12, an antioxidant, on oxidative stress in DE patients and revealed that eye drops reduced oxidative stress and eased DE symptoms. Vitamin E and vitamin C show a decrease in oxidative damage generated by nitric oxide and other free radicals and lead to the recovery of the ocular surface milieu.[38]

Polyunsaturated fatty acid

Essential FAs are crucial for maintaining good health; however, they cannot be synthesised by the human body.[51] The derivative of ω-3 FAs, eicosanoids, possess antioxidant and anti-inflammatory properties, while ω-6–derived eicosanoids exert proinflammatory effects[52] and suppress inflammation.[53] Intake of a high level of ω-3 FAs and a moderate level of ω-6 FAs leads to modulating FA composition and promotes tear stabilization while preventing blocked meibomian ducts.[39] The anti-inflammatory properties of ω-3 and -6 FAs could be a probable mechanism for the Mediterranean diet, rich in fish and olive oil, showing results of improvement in DE condition via reducing the inflammatory process on the ocular surface.[32] Similarly, a diet supplemented with eicosapentaenoic acid, docosahexaenoic acid, and gamma-linoleic acid led to a significant recovery from DE symptoms in extremely symptomatic participants with DED.[54] Oral treatment of primrose oil, containing ω-6 FAs, caused a decrease in contact lens discomfort and related DE symptoms.[40] Primrose oil derivatives linoleic acid and γ-linolenic acid improved the symptoms and increased overall lens relief in patients with contact lens–linked DE and subsequently improved tear production.

Amino acids

Amino acids (AAs) are naturally found in human tears, and studies have shown that the relative concentration of AAs varies from what is observed in serum.[55,56] This concentration fluctuates due to ocular dryness in DE patients.[56] A pilot clinical study on 20 candidates with mild to moderate DEDs treated for 2 weeks with saline eye drops rich in Leu, Gly, Pro, and Lys showed a significant recovery in signs and symptoms of DEs as treatment reduced the tear film protein expression of IL-1β, IL-6, TNF-α, and IFN-γ compared to that in those receiving hyaluronic acid alone.[41] Treatment with taurine, an amino-sulfonic acid, changes the tear proteome of DE patients and shifts it toward the profile of healthy control candidates.[42] Taurine has antioxidant properties and leads to recovery of mitochondrial function through stabilizing the Electron Transport Chain (ETC) cycle and preventing ROS production.[57]

Functional foods

Turmeric is one of the most important medicinal herbs. Its extract consists of phenolic and flavonoid compounds along with monosaccharides and polysaccharides, which can boost the immune system.[58] Curcumin, a derivative of turmeric, possesses anti-inflammatory activity. Particularly, it has shown inhibition properties against proinflammatory cytokines, such as IL-4 and IL-5, in the DED model of rodents.[29] In an in vitro hyperosmolarity-induced DE model, curcumin reduced the elevated production of IL-1β, IL-6, and TNF-α induced by hyperosmotic stress in human corneal epithelial cells.[30] Red ginseng is applied as a remedy for treating endocrine and immune disorders.[43] Bae et al.[43] reported that ginsenoside, a derivative of red ginseng, demonstrated anti-inflammatory properties. Oral intake of red ginseng revealed improvements in signs and symptoms of DED in two studies.[43,59] Bilberry extract, a rich source of the flavonoids anthocyanins, was reported to possess antioxidant, antiallergic, anti-inflammatory, antiviral, antiproliferative, and antimicrobial properties.[60] Riva et al.[44] showed that extracts from bilberry significantly improve tear secretion. Tea, Camellia sinensis, is one of the most consumed drinks globally. Green tea comprises several polyphenols such as catechins that possess antioxidant and immunomodulatory[45] as well as antiviral activities.[61] Green tea has been reported to act against oxidative stress, chronic diseases,[62] and serum lipid.[63] A double-blind, placebo-controlled study examined the efficacy of green tea and reported that it improves DE and meibomian gland dysfunction as it exerts antioxidative, antibacterial, antiandrogen, immunomodulatory, and anti-inflammatory properties[45] and revealed that it improves meibomian gland health and ocular comfort scores after 1 month of intervention. The probable reason could be the presence of epigallocatechin gallate, which exhibits inhibitory action against inflammation through the inhibition of IL-1, IL-6, MCP-1, TNF-α, and NF-kB” - Nejabat M et al (2017) reported that green tea improved clinical symptoms of dry eye where the main components from green tea is Epigallocatechin Gallate (EGCG). The substance has an inhibitory effect on inflammation, through the suppression of IL-1, IL-6, MCP-1 and TNF-α and through inhibition of NF-kB’s activation. This observation was supported Kaszkin M et al (2004) and Cavet M et al (2011).

Conclusion

Ocular disease is at an epidemic level in both developing and developed countries, with nearly 285 million individuals suffering from visual disorders. To meet this challenge, the development of affordable and novel therapies that provide not only a cure for DED but also improve the quality of lifestyle is crucially needed worldwide. Vitamins, AAs, and omega-3 FAs modulate many biochemical processes in the eye. Likewise, dietary modification and the involvement of functional food in the diet lead to several health benefits. Evidence obtained from various in vivo, in vitro, and diet-related clinical trials has assisted clinicians to manipulate nutritional recommendations for lifestyle- and age-related eye disease. A systemic procedure, comprising the intake of dietary supplements and lifestyle intervention, should be applied in addition to conventional treatment. For instance, adequate CR and/or calorie restriction CR mimetic therapy such as Mediterranean diet[32,64] or ketogenic diet[65] may be synergistic and important interventions against various DE disorders. Studies regarding the effects of CR on eye disease need to continue, with the aim of elucidating the molecular mechanisms underlying its favorable effects on age-related and inflammatory ocular disorders. CR mechanism-based agonists, such as food-derived or naturally occurring sirtuin activators and AMP-activated protein kinase (AMPK) upregulators, are anticipated to be utilized to facilitate the broad application of CR in clinical studies.

Financial support and sponsorship

The author declares that financial support was received by Co-corresponding – Dr. Rohit Shetty for by the research and publication of this article.

Conflicts of interest

All authors declare that there is no conflict of interest.

References

  • 1.The definition and classification of dry eye disease: Report of the definition and classification subcommittee of the international dry eye workshop (2007) Ocul Surf. 2007;5:75–92. doi: 10.1016/s1542-0124(12)70081-2. [DOI] [PubMed] [Google Scholar]
  • 2.Seen S, Tong L. Dry eye disease and oxidative stress. Acta Ophthalmol. 2018;96:e412–20. doi: 10.1111/aos.13526. [DOI] [PubMed] [Google Scholar]
  • 3.Sethu S, Nair AP, Dsouza S, Rohit S, Ghosh A. Distinct immune cell subsets on the ocular surface of dry eye disease and keratoconus patients is associated with pathology. Investig Ophthalmol Vis Sci. 2019;60:4734. [Google Scholar]
  • 4.Sagili S, Malhotra R. Dry eyes can be exacerbated by systemic antihypertensive medication. Scott Med J. 2012;57:121. doi: 10.1258/smj.2011.012011. [DOI] [PubMed] [Google Scholar]
  • 5.Lawrenson JG, Grzybowski A. Controversies in the use of nutritional supplements in ophthalmology. Curr Pharm Des. 2015;21:4667–72. doi: 10.2174/1381612821666150909095916. [DOI] [PubMed] [Google Scholar]
  • 6.Roncone M, Bartlett H, Eperjesi F. Essential fatty acids for dry eye: A review. Cont Lens Anterior Eye. 2010;33:49–54. doi: 10.1016/j.clae.2009.11.002. quiz 100. [DOI] [PubMed] [Google Scholar]
  • 7.Hong SC, Ha JH, Lee JK, Jung SH, Kim JC. In vivo anti-inflammation potential of aster koraiensis extract for dry eye syndrome by the protection of ocular surface. Nutrients. 2020;12:325. doi: 10.3390/nu12113245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Sommer A. Vitamin A deficiency and clinical disease: An historical overview. J Nutr. 2008;138:1835–9. doi: 10.1093/jn/138.10.1835. [DOI] [PubMed] [Google Scholar]
  • 9.Akhtar S, Ahmed A, Randhawa MA, Atukorala S, Arlappa N, Ismail T, et al. Prevalence of vitamin a deficiency in south asia: Causes, outcomes, and possible remedies. J Health Popul Nutr. 2013;31:413–23. doi: 10.3329/jhpn.v31i4.19975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Khamar P, Nair AP, Shetty R, Vaidya T, Subramani M, Ponnalagu M, et al. Dysregulated tear fluid nociception-associated factors, corneal dendritic cell density, and vitamin d levels in evaporative dry eye. Investig Ophthalmol Vis Sci. 2019;60:2532–42. doi: 10.1167/iovs.19-26914. [DOI] [PubMed] [Google Scholar]
  • 11.Murugeswari P, Firoz A, Murali S, Vinekar A, Krishna L, Anandula VR, et al. Vitamin-d3 (α-1, 25 (oh) 2d3) protects retinal pigment epithelium from hyperoxic insults. Invest Ophthalmol Vis Sci. 2020;61:4. doi: 10.1167/iovs.61.2.4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Bhargava R, Kumar P, Arora Y. Short-term omega 3 fatty acids treatment for dry eye in young and middle-aged visual display terminal users. Eye Contact Lens. 2016;42:231–6. doi: 10.1097/ICL.0000000000000179. [DOI] [PubMed] [Google Scholar]
  • 13.Galbis-Estrada C, Pinazo-Duran MD, Martinez-Castillo S, Morales JM, Monleon D, Zanon-Moreno V. A metabolomic approach to dry eye disorders. The role of oral supplements with antioxidants and omega 3 fatty acids. Mol Vis. 2015;21:555–67. [PMC free article] [PubMed] [Google Scholar]
  • 14.Arpón A, Milagro FI, Razquin C, Corella D, Estruch R, Fitó M, et al. Impact of consuming extra-virgin olive oil or nuts within a mediterranean diet on DNA methylation in peripheral white blood cells within the predimed-navarra randomized controlled trial: A role for dietary lipids. Nutrients. 2017;10:15. doi: 10.3390/nu10010015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kojima G, Avgerinou C, Iliffe S, Walters K. Adherence to mediterranean diet reduces incident frailty risk: Systematic review and meta‐analysis. J Am Geriatr Soc. 2018;66:783–8. doi: 10.1111/jgs.15251. [DOI] [PubMed] [Google Scholar]
  • 16.Viau S, Maire MA, Pasquis B, Gregoire S, Acar N, Bron AM, et al. Efficacy of a 2-month dietary supplementation with polyunsaturated fatty acids in dry eye induced by scopolamine in a rat model. Graefes Arch Clin Exp Ophthalmol. 2009;247:1039–50. doi: 10.1007/s00417-009-1080-z. [DOI] [PubMed] [Google Scholar]
  • 17.Shearer GC, Borkowski K, Puumala SL, Harris WS, Pedersen TL, Newman JW. Abnormal lipoprotein oxylipins in metabolic syndrome and partial correction by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids. 2018;128:1–10. doi: 10.1016/j.plefa.2017.10.006. [DOI] [PubMed] [Google Scholar]
  • 18.Wakamatsu TH, Dogru M, Matsumoto Y, Kojima T, Kaido M, Ibrahim OM, et al. Evaluation of lipid oxidative stress status in sjögren syndrome patients. Invest Ophthalmol Vis Sci. 2013;54:201–10. doi: 10.1167/iovs.12-10325. [DOI] [PubMed] [Google Scholar]
  • 19.Pinazo-Durán MD, Gallego-Pinazo R, Garcia-Medina JJ, Zanón-Moreno V, Nucci C, Dolz-Marco R, et al. Oxidative stress and its downstream signaling in aging eyes. Clin Interv Aging. 2014;9:637–52. doi: 10.2147/CIA.S52662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Bron AJ, de Paiva CS, Chauhan SK, Bonini S, Gabison EE, Jain S, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017;15:438–510. doi: 10.1016/j.jtos.2017.05.011. [DOI] [PubMed] [Google Scholar]
  • 21.Massingale ML, Li X, Vallabhajosyula M, Chen D, Wei Y, Asbell PA. Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea. 2009;28:1023–7. doi: 10.1097/ICO.0b013e3181a16578. [DOI] [PubMed] [Google Scholar]
  • 22.Jackson DC, Zeng W, Wong CY, Mifsud EJ, Williamson NA, Ang C-S, et al. Tear interferon-gamma as a biomarker for evaporative dry eye disease. Invest Ophthalmol Vis Sci. 2016;57:4824–30. doi: 10.1167/iovs.16-19757. [DOI] [PubMed] [Google Scholar]
  • 23.Acera A, Rocha G, Vecino E, Lema I, Durán JA. Inflammatory markers in the tears of patients with ocular surface disease. Ophthalmic Res. 2008;40:315–21. doi: 10.1159/000150445. [DOI] [PubMed] [Google Scholar]
  • 24.Kawashima M, Kawakita T, Okada N, Ogawa Y, Murat D, Nakamura S, et al. Calorie restriction: A new therapeutic intervention for age-related dry eye disease in rats. Biochem Biophys Res Commun. 2010;397:724–8. doi: 10.1016/j.bbrc.2010.06.018. [DOI] [PubMed] [Google Scholar]
  • 25.Zhang W, Li W, Zhang C, Zhu C, Yi X, Zhou Y, et al. Effects of vitamin a on expressions of apoptosis genes bax and bcl-2 in epithelial cells of corneal tissues induced by benzalkonium chloride in mice with dry eye. Med Sci Monit. 2019;25:4583–9. doi: 10.12659/MSM.913478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.James G, Bohannan W, Adewunmi E, Schmidt K, Park HG, Shchepinov MS, et al. Pharmacokinetics and metabolism in mouse retina of bis-allylic deuterated docosahexaenoic acid (d-dha), a new dry amd drug candidate. Exp Eye Res. 2022;222:109193. doi: 10.1016/j.exer.2022.109193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Pehlivan SB, Yavuz B, Calamak S, Ulubayram K, Kaffashi A, Vural I, et al. Preparation and in vitro/in vivo evaluation of cyclosporin a-loaded nanodecorated ocular implants for subconjunctival application. J Pharm Sci. 2015;104:1709–20. doi: 10.1002/jps.24385. [DOI] [PubMed] [Google Scholar]
  • 28.Mori M, De Lorenzo E, Torre E, Fragai M, Nativi C, Luchinat C, et al. A highly soluble matrix metalloproteinase-9 inhibitor for potential treatment of dry eye syndrome. Basic Clin Pharmacol Toxicol. 2012;111:289–95. doi: 10.1111/j.1742-7843.2012.00896.x. [DOI] [PubMed] [Google Scholar]
  • 29.Chung S-H, Choi SH, Choi JA, Chuck RS, Joo C-K. Curcumin suppresses ovalbumin-induced allergic conjunctivitis. Mol Vis. 2012;18:1966–72. [PMC free article] [PubMed] [Google Scholar]
  • 30.Chen M, Hu D-N, Pan Z, Lu C-W, Xue C-Y, Aass I. Curcumin protects against hyperosmoticity-induced il-1β elevation in human corneal epithelial cell via mapk pathways. Exp Eye Res. 2010;90:437–43. doi: 10.1016/j.exer.2009.12.004. [DOI] [PubMed] [Google Scholar]
  • 31.Kawashima M, Sano K, Takechi S, Tsubota K. Impact of lifestyle intervention on dry eye disease in office workers: A randomized controlled trial. J Occup Health. 2018;60:281–8. doi: 10.1539/joh.2017-0191-OA. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Molina-Leyva I, Molina-Leyva A, Riquelme-Gallego B, Cano-Ibáñez N, García-Molina L, Bueno-Cavanillas A. Effectiveness of mediterranean diet implementation in dry eye parameters: A study of predimed-plus trial. Nutrients. 2020;12:1289. doi: 10.3390/nu12051289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Alanazi SA, El-Hiti GA, Al-Baloud AA, Alfarhan MI, Al-Shahrani A, Albakri AA, et al. Effects of short-term oral vitamin a supplementation on the ocular tear film in patients with dry eye. Clin Ophthalmol. 2019;13:599–604. doi: 10.2147/OPTH.S198349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Ziada HEA. Oral versus topical vitamin a antioxidant in treatment of dry eye syndrome. Int J Ophthalmic Res. 2017;3:252–8. [Google Scholar]
  • 35.Kizilgul M, Kan S, Ozcelik O, Beysel S, Apaydin M, Ucan B, et al. Vitamin D replacement improves tear osmolarity in patients with vitamin D deficiency. Semin Ophthalmol. 2018;33:589–94. doi: 10.1080/08820538.2017.1358752. [DOI] [PubMed] [Google Scholar]
  • 36.Najjaran M, Zarei-Ghanavati S, Arjmand Askari E, Eslampoor A, Ziaei M. Effect of oral vitamin D supplementation on dry eye disease patients with vitamin d deficiency. Clin Exp Optom. 2022;106:1–6. doi: 10.1080/08164622.2022.2033601. [DOI] [PubMed] [Google Scholar]
  • 37.Macri A, Scanarotti C, Bassi AM, Giuffrida S, Sangalli G, Traverso CE, et al. Evaluation of oxidative stress levels in the conjunctival epithelium of patients with or without dry eye, and dry eye patients treated with preservative-free hyaluronic acid 0.15% and vitamin b12 eye drops. Graefes Arch Clin Exp Ophthalmol. 2015;253:425–30. doi: 10.1007/s00417-014-2853-6. [DOI] [PubMed] [Google Scholar]
  • 38.Peponis V, Papathanasiou M, Kapranou A, Magkou C, Tyligada A, Melidonis A, et al. Protective role of oral antioxidant supplementation in ocular surface of diabetic patients. Br J Ophthalmol. 2002;86:1369–73. doi: 10.1136/bjo.86.12.1369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Wojtowicz JC, Butovich I, Uchiyama E, Aronowicz J, Agee S, McCulley JP. Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye. Cornea. 2011;30:308–14. doi: 10.1097/ICO.0b013e3181f22e03. [DOI] [PubMed] [Google Scholar]
  • 40.Kokke KH, Morris JA, Lawrenson JG. Oral omega-6 essential fatty acid treatment in contact lens associated dry eye. Cont Lens Anterior Eye. 2008;31:141–6. doi: 10.1016/j.clae.2007.12.001. quiz 170. [DOI] [PubMed] [Google Scholar]
  • 41.Lambiase A, Sullivan BD, Schmidt TA, Sullivan DA, Jay GD, Truitt ER, et al. A two-week, randomized, double-masked study to evaluate safety and efficacy of lubricin (150 μg/ml) eye drops versus sodium hyaluronate (ha) 0.18% eye drops (vismed®) in patients with moderate dry eye disease. Ocul Surf. 2017;15:77–87. doi: 10.1016/j.jtos.2016.08.004. [DOI] [PubMed] [Google Scholar]
  • 42.Funke S, Azimi D, Wolters D, Grus FH, Pfeiffer N. Longitudinal analysis of taurine induced effects on the tear proteome of contact lens wearers and dry eye patients using a rp-rp-capillary-hplc–maldi tof/tof ms approach. J Proteomics. 2012;75:3177–90. doi: 10.1016/j.jprot.2012.03.018. [DOI] [PubMed] [Google Scholar]
  • 43.Bae HW, Kim JH, Kim S, Kim M, Lee N, Hong S, et al. Effect of korean red ginseng supplementation on dry eye syndrome in glaucoma patients–A randomized, double-blind, placebo-controlled study. J Ginseng Res. 2015;39:7–13. doi: 10.1016/j.jgr.2014.07.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Riva A, Togni S, Franceschi F, Kawada S, Inaba Y, Eggenhoffner R, et al. The effect of a natural, standardized bilberry extract (mirtoselect®) in dry eye: A randomized, double blinded, placebo-controlled trial. Eur Rev Med Pharmacol Sci. 2017;21:2518–25. [PubMed] [Google Scholar]
  • 45.Nejabat M, Reza SA, Zadmehr M, Yasemi M, Sobhani Z. Efficacy of green tea extract for treatment of dry eye and meibomian gland dysfunction; a double-blind randomized controlled clinical trial study. J Clin Diagn Res. 2017;11:NC05–8. doi: 10.7860/JCDR/2017/23336.9426. doi: 10.7860/JCDR/2017/23336.9426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Bordone L, Guarente L. Calorie restriction, sirt1 and metabolism: Understanding longevity. Nat Rev Mol Cell Biol. 2005;6:298–305. doi: 10.1038/nrm1616. [DOI] [PubMed] [Google Scholar]
  • 47.Fontana L, Weiss EP, Villareal DT, Klein S, Holloszy JO. Long‐term effects of calorie or protein restriction on serum igf‐1 and igfbp‐3 concentration in humans. Aging Cell. 2008;7:681–7. doi: 10.1111/j.1474-9726.2008.00417.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Heilbronn LK, De Jonge L, Frisard MI, DeLany JP, Larson-Meyer DE, Rood J, et al. Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: A randomized controlled trial. JAMA. 2006;295:1539–48. doi: 10.1001/jama.295.13.1539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Al-Ani A, Ramaesh K, Wykes W. Diagnosis of vitamin a deficiency from its ocular manifestations in a british patient. Can J Ophthalmol/Journal Canadien d’ophtalmologie. 2009;5:e43. doi: 10.3129/i09-114. [DOI] [PubMed] [Google Scholar]
  • 50.Yang C-H, Albietz J, Harkin DG, Kimlin MG, Schmid KL. Impact of oral vitamin D supplementation on the ocular surface in people with dry eye and/or low serum vitamin D. Cont Lens Anterior Eye. 2018;41:69–76. doi: 10.1016/j.clae.2017.09.007. [DOI] [PubMed] [Google Scholar]
  • 51.Sokoła-Wysoczańska E, Wysoczański T, Wagner J, Czyż K, Bodkowski R, Lochyński S, et al. Polyunsaturated fatty acids and their potential therapeutic role in cardiovascular system disorders—A review. Nutrients. 2018;10:1561. doi: 10.3390/nu10101561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Sapieha P, Stahl A, Chen J, Seaward MR, Willett KL, Krah NM, et al. 5-lipoxygenase metabolite 4-hdha is a mediator of the antiangiogenic effect of ω-3 polyunsaturated fatty acids. Sci Transl Med. 2011;3:69ra12. doi: 10.1126/scitranslmed.3001571. doi: 10.1126/scitranslmed.3001571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Hobbs RP, Bernstein PS. Nutrient supplementation for age-related macular degeneration, cataract, and dry eye. J Ophthalmic Vis Res. 2014;9:487–93. doi: 10.4103/2008-322X.150829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Ng A, Woods J, Jahn T, Jones LW, Sullivan Ritter J. Effect of a novel omega-3 and omega-6 fatty acid supplement on dry eye disease: A 3-month randomized controlled trial. Optom Vis Sci. 2022;99:67–75. doi: 10.1097/OPX.0000000000001826. [DOI] [PubMed] [Google Scholar]
  • 55.ChenZhuo L, Murube J, Latorre A, Río RMd. Lacrimal Gland, Tear Film, and Dry Eye Syndromes 3. Springer; 2002. Different concentrations of amino acids in tears of normal and human dry eyes; pp. 617–21. [DOI] [PubMed] [Google Scholar]
  • 56.Nakatsukasa M, Sotozono C, Shimbo K, Ono N, Miyano H, Okano A, et al. Amino acid profiles in human tear fluids analyzed by high-performance liquid chromatography and electrospray ionization tandem mass spectrometry. Am J Ophthalmol. 2011;151:799–808.e1. doi: 10.1016/j.ajo.2010.11.003. [DOI] [PubMed] [Google Scholar]
  • 57.Jong CJ, Azuma J, Schaffer S. Mechanism underlying the antioxidant activity of taurine: Prevention of mitochondrial oxidant production. Amino Acids. 2012;42:2223–32. doi: 10.1007/s00726-011-0962-7. [DOI] [PubMed] [Google Scholar]
  • 58.Akaberi M, Sahebkar A, Emami SA. Turmeric and curcumin: From traditional to modern medicine. Adv Exp Med Biol. 2021;1291:15–39. doi: 10.1007/978-3-030-56153-6_2. [DOI] [PubMed] [Google Scholar]
  • 59.Kim N-R, Kim J-H, Kim C-Y. Effect of korean red ginseng supplementation on ocular blood flow in patients with glaucoma. J Ginseng Res. 2010;34:237–45. [Google Scholar]
  • 60.Ghosh D, Konishi T. Anthocyanins and anthocyanin-rich extracts: Role in diabetes and eye function. Asia Pac J Clin Nutr. 2007;16:200–8. [PubMed] [Google Scholar]
  • 61.Song J-M, Lee K-H, Seong B-L. Antiviral effect of catechins in green tea on influenza virus. Antiviral Res. 2005;68:66–74. doi: 10.1016/j.antiviral.2005.06.010. [DOI] [PubMed] [Google Scholar]
  • 62.Forester SC, Lambert JD. The role of antioxidant versus pro‐oxidant effects of green tea polyphenols in cancer prevention. Mol Nutr Food Res. 2011;55:844–54. doi: 10.1002/mnfr.201000641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Rains TM, Agarwal S, Maki KC. Antiobesity effects of green tea catechins: A mechanistic review. J Nutr Biochem. 2011;22:1–7. doi: 10.1016/j.jnutbio.2010.06.006. [DOI] [PubMed] [Google Scholar]
  • 64.Li L, Jin R, Li Y, Yoon HS, Yoon HJ, Yoon KC. Effects of eye drops containing a mixture of 3% diquafosol sodium and tocopherol acetate (vitamin e) on the ocular surface of murine dry eye. Cutan Ocul Toxicol. 2021;40:350–8. doi: 10.1080/15569527.2021.1973022. [DOI] [PubMed] [Google Scholar]
  • 65.Vicario-de-la-Torre M, Benitez-del-Castillo JM, Vico E, Guzman M, de-Las-Heras B, Herrero-Vanrell R, et al. Design and characterization of an ocular topical liposomal preparation to replenish the lipids of the tear film. Invest Ophthalmol Vis Sci. 2014;55:7839–47. doi: 10.1167/iovs.14-14700. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Ophthalmology are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES